Latest news

Find the latest news about Elanco and its products. Check our news archives for previous stories.

Media and general inquiries should be directed to:

Elanco Animal Health

2500 Innovation Way
Greenfield, IN 46140
1-800-428-4441 or 1-317-277-3185

Corporate news

Food news

Pet news

April 22, 2014

Elanco acquires Novartis Animal Health

Elanco announces an agreement to acquire Novartis Animal Health, creating a global leader in animal health innovation and customer value. The $5.4 billion deal creates world’s second-largest animal health company.

February 24, 2014

Elanco acquires Lohmann SE

Elanco announces an agreement to acquire Lohmann Animal Health, a privately-held company headquartered in Cuxhaven, Germany. The acquisition will establish Elanco as a global poultry leader, extending our presence into layers and expanding our growing vaccine presence.

February 13, 2014

'Enough is Enough' When It Comes to the Food Security Debate

  • Innovation, Choice and Trade - the Three Pillars for Ensuring a Food Secure World before 2050

  • The report, written by Elanco President Jeff Simmons, advocates for farmer access to innovative tools in order to feed a growing global population and save natural resources.

  • Elanco conducted the second edition (2013) of the International Consumer Attitudes Study to determine the key issues for consumers when buying food. Based on two key criteria – 1) unaided questions and 2) consumer spending data, the research includes 34 studies from 26 countries accounting for more than 100,000 consumers.  

  • For more information, visit  Join @JeffSimmons2050 and @Elanco for more discussion on Twitter with #FeedThe9.  The website calls for advocates to join The Enough Movement and provides resources for campaigners to help make their voices heard in the fight for a food secure tomorrow.



February 16, 2012

Hygromix® returns to help poultry producers fight intestinal worms

Hygromix, an in-feed medication for control of parasite infections in chickens, will once again be available in the United States starting mid-April. Hygromix is the only FDA-approved poultry product that controls all three nematodes; capillary worms (Capillaria obsignata), cecal worms (Heterakis gallinae) and large roundworms (Ascaris galli), and is recommended for pullets and breeders.

  • For use as an aid in the control of parasite infections in chicken flocks associated with Ascaris galli, Heterakis gallinae and Capillaria obsignata.
  • Mix 1.0–1.5 lbs. Hygromix 8 per ton of Type C medicated feed for 8–12 g of hygromycin B per ton.
  • Feeds containing Hygromix must be withdrawn 3 days prior to slaughter.

The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions

August 24, 2012

Elanco Announces Comfortis® (spinosad) for Cats and Small Dogs

Comfortis® (spinosad), the month-long flavored tablet that has been protecting dogs from fleas since 2007 has now been approved for use in cats and smaller dogs. As a result of the recent FDA approval, Comfortis can now be used in cats and kittens greater than 2 lbs and 14 weeks and older. In addition, our new 90 mg tablet will allow veterinarians to prescribe Comfortis for smaller dogs 3.3-4.9 lbs and 14 weeks and older.

Important safety information

For cats: The most common adverse reaction recorded in clinical trials was vomiting. Other adverse reactions were: lethargy, decreased appetite, weight loss, and diarrhea. Use with caution with concomitant extra-label use of ivermectin.

The safe use of Comfortis in breeding, pregnant, or lactating cats has not been evaluated.

For dogs: The most common adverse reaction reported is vomiting. Other adverse reactions reported in decreasing order of frequency are: depression/lethargy, decreased appetite, incoordination, diarrhea, itching, trembling, excessive salivation and seizures.

Following concomitant extra-label use of ivermectin with Comfortis, some dogs have experienced the following clinical signs: trembling/twitching, salivation/ drooling, seizures, incoordination, excessive dilation of pupils, blindness and disorientation. Post-approval experience continues to support the safety of Comfortis when used concurrently with heartworm preventatives according to label directions.

Use with caution in breeding females and dogs with pre-existing epilepsy. The safe use of Comfortis in breeding males has not been evaluated.

View full product label for complete safety information